Effect of Modified Vaccinia Ankara–5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer: A Randomized Clinical Trial

IMPORTANCE: The success of immunotherapy with checkpoint inhibitors is not replicated in most cases of colorectal cancer; therefore, different strategies are urgently required. The oncofetal antigen 5T4 is expressed in more than 90% of cases of metastatic colorectal cancer (mCRC). Preliminary data u...

Descripción completa

Detalles Bibliográficos
Autores principales: Scurr, Martin, Pembroke, Tom, Bloom, Anja, Roberts, David, Thomson, Amanda, Smart, Kathryn, Bridgeman, Hayley, Adams, Richard, Brewster, Alison, Jones, Robert, Gwynne, Sarah, Blount, Daniel, Harrop, Richard, Wright, Melissa, Hills, Robert, Gallimore, Awen, Godkin, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2017
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824319/
https://www.ncbi.nlm.nih.gov/pubmed/28880972
http://dx.doi.org/10.1001/jamaoncol.2017.2579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824319/
https://www.ncbi.nlm.nih.gov/pubmed/28880972
http://dx.doi.org/10.1001/jamaoncol.2017.2579

Ejemplares similares